Glenmede Trust Company »

First Tracks Biotherapeutics shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $246k 12k 20.12

More positions owned by Glenmede Trust Company

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Ishares Tr Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Rusel 2500 Etf (SMMD)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Putnam Etf Trust Focused Lar Cap (PVAL)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Vanguard Index Fds Small Cp Etf (VB)

View all positions for Glenmede Trust Company

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics